Control of Acute Myeloid Leukemia by a Trifunctional NKp46-CD16a-NK Cell Engager Targeting CD123

Researchers engineered a trifunctional natural killer cell engager (NKCE) that targeted CD123, the alpha chain of the IL-3 receptor, on acute myeloid leukemia blasts and NKp46 and CD16a on NK cells.